南米および中米バイオプロダクション市場予測 2030年 - 地域別分析 - 製品別(生物製剤およびバイオシミラー、ワクチン、細胞および遺伝子治療、核酸治療、その他)、用途別(関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、その他)、機器別(上流機器、下流機器、バイオリアクター、消耗品および付属品)、エンドユーザー別(バイオ医薬品会社、契約製造組織、その他)

BMIRE00030062 | Pages: 95 | Biotechnology | May 2024 | Type: Regional | Status: Published
南米および中米のバイオプロダクション市場は、2022年に7億9,967万米ドルと評価され、2030年までに19億6,521万米ドルに達すると予想されています。また、2022年から2030年にかけて11.9%のCAGRを記録すると予測されています。

ブロックバスター生物製剤の特許切れが南米および中米のバイオプロダクション市場を活性化

生物製剤は、これまで治療不可能だった疾患に対する有望な新しい治療法であり、医薬品市場で非常に重要になりつつあります。オリジナルの生物製剤の特許は、今後数年間で失効すると予想されています。

ベストセラーの生物製剤の推定特許および独占権の失効日を次の表に示します。

生物学的製剤

有効期限

アバスチン

2022 年 1 月

サイラムザ

2023 年 5 月

アドセトリス

2023 年 8 月

アブスラックス

2024 年 10 月

ガザイバ/ガザイバロ

2024 年 11 月

ダルザレックス

2026 年 5 月

オクレラス

2027 年 4 月

エムガリティ

2028 年 9 月

ヘムリブラ

2028 年 2 月

ルメトリ

2028 年 3 月

イムフィンジ

2028 年 9 月

マイロターグ

2028 年 4 月

イムフィンジ

2028 年 9 月

マイロターグ

2028 年 4 月

シルバント

7 月2034年

オリジネーター生物製剤の特許の満了やその他の知的財産権により、将来的に新しいバイオシミラーを導入する必要が生じます。その結果、今後数年間で市場プレーヤー間の競争が激化するでしょう。したがって、ブロックバスター生物製剤の特許の満了により、予測期間中にバイオプロダクション市場に有利な機会が生まれることが期待されます。

南米および中米のバイオプロダクション市場の概要

南米および中米のバイオプロダクション市場は、ブラジル、アルゼンチン、その他の南米および中米に細分化されています。医療業界の発展とブラジルの細胞療法に関する意識の高まりは、市場の成長に大きな成長機会を生み出す可能性があります。同様に、アルゼンチンのヘルスケア業界の成長は、バイオプロダクション市場に成長機会をもたらすと予想されます。

Biomaterials Researchに掲載された記事によると、2020年にブラジルは糖尿病患者の数が最も多い国として世界のトップ10にランクされ、現在は5位にランクされています。現在、ブラジルは成人の糖尿病(DM)の有病率が世界で5番目に高い国です。国際糖尿病連合(IDF)によると、2045年までに糖尿病の新規症例が54.7%増加すると推定されています。

GaBIによると、2022年にブラジル保健規制庁(Agência Nacional de Vigilância Sanitária、ANVISA)は、インスリン、モノクローナル抗体、腫瘍壊死因子(TNF)阻害剤、ヒト成長ホルモン、抗凝固剤およびヘパリン、顆粒球コロニー刺激因子の製品クラス内で30のバイオシミラーをブラジルで使用することを承認しました。ANVISAは、ブラジルで糖尿病の治療薬としてサノフィのAdmelogバイオシミラーを承認しました。このように、ブラジルでの糖尿病症例の増加と製品承認の増加がバイオプロダクション市場を牽引しています。



南米および中米のバイオプロダクション市場の収益と2030年までの予測(百万米ドル)



南米および中米のバイオプロダクション市場のセグメンテーション



南米および中米のバイオプロダクション市場は、製品、アプリケーション、機器、エンドユーザー、および国に分類されています。

製品に基づいて、南米および中米のバイオプロダクション市場は、生物製剤とバイオシミラー、ワクチン、細胞および遺伝子治療、核酸治療、およびその他に分類されています。 生物製剤とバイオシミラーセグメントは、2022年に南米および中米のバイオプロダクション市場で最大のシェアを占めました。

アプリケーションの観点から、南米および中米のバイオプロダクション市場は、関節リウマチ、血液疾患、がん、糖尿病、心血管疾患、およびその他に分類されています。 がんセグメントは、2022年に南米および中米のバイオプロダクション市場で最大のシェアを占めました。

機器別に見ると、南米および中米のバイオ生産市場は、上流機器、下流機器、バイオリアクター、消耗品および付属品に分かれています。消耗品および付属品セグメントは、2022年に南米および中米のバイオ生産市場で最大のシェアを占めました。

エンドユーザー別に見ると、南米および中米のバイオ生産市場は、バイオ医薬品会社、契約製造組織、その他に分類されています。バイオ医薬品会社セグメントは、2022年に南米および中米のバイオ生産市場で最大のシェアを占めました。

国別に見ると、南米および中米のバイオ生産市場は、ブラジル、アルゼンチン、その他の南米および中米に分かれています。 2022年、南米および中米のバイオ生産市場シェアはブラジルが独占しました。

南米および中米のバイオ生産市場で事業を展開している大手企業には、Lonza Group AG、Danaher Corp、Sartorius AG、Thermo Fisher Scientific Inc、Merck KGaA、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc. などがあります。

Table of Content

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. South & Central America Bioproduction Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Rising Adoption of Regenerative Medicines

4.1.2 Increasing Prevalence of Chronic Diseases

4.2 Market Restraints

4.2.1 High Cost of Cell Therapy and Biosimilar Manufacturing

4.3 Market Opportunities

4.3.1 Patent Expiry of Blockbuster Biologics

4.4 Future Trends

4.4.1 Shift Toward Automated Cell Therapy Manufacturing

4.5 Impact Analysis

5. Bioproduction Market - South & Central America Market Analysis

5.1 South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030

6. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Biologics and Biosimilars

6.3.1 Overview

6.3.2 Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Vaccines

6.4.1 Overview

6.4.2 Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Cell and Gene Therapies

6.5.1 Overview

6.5.2 Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Nucleic Acid Therapeutics

6.6.1 Overview

6.6.2 Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Cancer

7.3.1 Overview

7.3.2 Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Cardiovascular Diseases

7.4.1 Overview

7.4.2 Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Rheumatoid Arthritis

7.5.1 Overview

7.5.2 Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Hematological Disorders

7.6.1 Overview

7.6.2 Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Diabetes

7.7.1 Overview

7.7.2 Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

7.8 Others

7.8.1 Overview

7.8.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by Equipment

8.1 Overview

8.2 South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)

8.3 Consumables and Accessories

8.3.1 Overview

8.3.2 Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Downstream Equipment

8.4.1 Overview

8.4.2 Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Bioreactors

8.5.1 Overview

8.5.2 Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

8.5.2.1 South & Central America: Bioproduction Market, For Bioreactors by Equipment, 2020-2030 (US$ Million)

8.6 Upstream Equipment

8.6.1 Overview

8.6.2 Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - by End User

9.1 Overview

9.2 South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)

9.3 Biopharmaceutical Companies

9.3.1 Overview

9.3.2 Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Contract Manufacturing Organizations

9.4.1 Overview

9.4.2 Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Others

9.5.1 Overview

9.5.2 Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Bioproduction Market - Revenue and Forecast to 2030 - Country Analysis

10.1 South & Central America: Bioproduction Market

10.1.1 South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)

10.1.1.1 Brazil: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2 Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)

10.1.1.2.1 Brazil: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.2.2 Brazil: Bioproduction Market, By Application, 2020-2030 (US$ Million)

10.1.1.2.3 Brazil: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)

10.1.1.2.3.1 Brazil: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.2.4 Brazil: Bioproduction Market, By End User, 2020-2030 (US$ Million)

10.1.1.3 Argentina: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.4 Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)

10.1.1.4.1 Argentina: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.4.2 Argentina: Bioproduction Market, By Application, 2020-2030 (US$ Million)

10.1.1.4.3 Argentina: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)

10.1.1.4.3.1 Argentina: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.4.4 Argentina: Bioproduction Market, By End User, 2020-2030 (US$ Million)

10.1.1.5 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.5.1 Overview

10.1.1.6 Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.6.1 Rest of South & Central America: Bioproduction Market, by Product, 2020-2030 (US$ Million)

10.1.1.6.2 Rest of South & Central America: Bioproduction Market, By Application, 2020-2030 (US$ Million)

10.1.1.6.3 Rest of South & Central America: Bioproduction Market, By Equipment, 2020-2030 (US$ Million)

10.1.1.6.3.1 Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment, 2020-2030 (US$ Million)

10.1.1.6.4 Rest of South & Central America: Bioproduction Market, By End User, 2020-2030 (US$ Million)

11. Bioproduction Market-Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Bioproduction Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profiles

12.1 Lonza Group AG

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Danaher Corp

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Sartorius AG

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Thermo Fisher Scientific Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Merck KGaA

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 F. Hoffmann-La Roche Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Bio-Rad Laboratories Inc

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About Us

13.2 Glossary of Terms

 

 

 

List of Tables

Table 1. South & Central America Bioproduction Market Segmentation

Table 2. South & Central America Bioproduction Market, For Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 3. Brazil: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 4. Brazil: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)

Table 5. Brazil: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 6. Brazil: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 7. Brazil: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)

Table 8. Argentina: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. Argentina: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. Argentina: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 11. Argentina: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 12. Argentina: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)

Table 13. Rest of South & Central America: Bioproduction Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 14. Rest of South & Central America: Bioproduction Market, By Application - Revenue and Forecast to 2030 (US$ Million)

Table 15. Rest of South & Central America: Bioproduction Market, By Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 16. Rest of South & Central America: Bioproduction Market, for Bioreactors by Equipment - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of South & Central America: Bioproduction Market, By End User - Revenue and Forecast to 2030 (US$ Million)

Table 18. Recent Inorganic Growth Strategies in the Bioproduction Market

Table 19. Recent Organic Growth Strategies in the Bioproduction Market

Table 20. Glossary of Terms, Bioproduction Market

 

List of Figures

Figure 1. South & Central America Bioproduction Market Segmentation, By Country

Figure 2. South & Central America Bioproduction Market: Key Industry Dynamics

Figure 3. South & Central America Bioproduction Market: Impact Analysis of Drivers and Restraints

Figure 4. South & Central America Bioproduction Market Revenue (US$ Mn), 2020 - 2030

Figure 5. South & Central America Bioproduction Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Biologics and Biosimilars: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Vaccines: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Cell and Gene Therapies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Nucleic Acid Therapeutics: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. South & Central America Bioproduction Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Cancer: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Cardiovascular Diseases: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Rheumatoid Arthritis: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Hematological Disorders: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Diabetes: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. South & Central America Bioproduction Market Revenue Share, by Equipment 2022 & 2030 (%)

Figure 19. Consumables and Accessories: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Downstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Bioreactors: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Upstream Equipment: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. South & Central America Bioproduction Market Revenue Share, by End User 2022 & 2030 (%)

Figure 24. Biopharmaceutical Companies: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. Contract Manufacturing Organizations: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Others: South & Central America Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. South & Central America: Bioproduction Market, By Key Country - Revenue (2022) (US$ Million)

Figure 28. South & Central America: Bioproduction Market Share by Country - 2022 & 2030, (%)

Figure 29. Brazil: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)

Figure 30. Argentina: Bioproduction Market- Revenue and Forecasts to 2030 (US$ Million)

Figure 31. Rest of South & Central America: Bioproduction Market - Revenue and Forecast to 2030 (US$ Million)

Figure 32. Growth Strategies in the Bioproduction Market

1. Lonza Group AG

 

2. Danaher Corp

3. Sartorius AG

4. Thermo Fisher Scientific Inc

5. Merck KGaA

6. F. Hoffmann-La Roche Ltd

7. Bio-Rad Laboratories Inc

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bioproduction market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America bioproduction market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America bioproduction market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440